Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03271983 · ClinicalTrials.gov registry record · Early Phase 1
Pharmacokinetics of Metronidazole Dermal Products
A Early Phase 1 study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 7
- Enrollment target
NCT03271983 is a Early Phase 1 study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 7 participants.
The verdict
NCT03271983, a Early Phase 1 study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 7 participants
- Enrollment target
Study Summary
Generate human PK data by collecting data following the application of metronidazole formulations.
Interventions
- DRUG Metronidazole gel 1
- DRUG Metronidazole gel 2
- DRUG Metronidazole cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2019-04-09 |
| Est. Completion | 2019-11-03 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03271983
The ClinicalTrials.gov registry entry for NCT03271983 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Metronidazole gel 1 is the first listed.
NCT03271983 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03271983 about?
NCT03271983 is a clinical study titled "Pharmacokinetics of Metronidazole Dermal Products". Generate human PK data by collecting data following the application of metronidazole formulations.
What is the current status of trial NCT03271983?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 7 participants. The study started on 2019-04-09. Estimated completion is 2019-11-03.
What interventions are being tested in trial NCT03271983?
The interventions under investigation include: Metronidazole gel 1 (DRUG), Metronidazole gel 2 (DRUG), Metronidazole cream (DRUG).
Who is sponsoring clinical trial NCT03271983?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.